Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DUSA (DUSA) Pharmaceutical -- Ignore unavailable to you. Want to Upgrade?

To: bdusa1 who wrote (37)	7/27/1998 11:57:00 PM
From: ouija	Respond to of 101

No on hardballing. The deal was pulled by Dusa because they were being left to drift while the big pharma (Bristol) worked out various deals to minimize impact of dollars to Dusa upfront on bottom line. Dusa not an issue. (at least one person I know of has validated this through Bristol) Due to reaction of not meeting a self imposed deadline the first time around we will know nothing until a deal is signed sealed and delivered this time. News flow should be forthcoming from the company. Next new information besides status of NDA should be about bladder cancer diagnosis. At this point we are playing a game of chicken as far as the stock goes: how long can I (a fund) wait before the stock starts to anticipate a deal or the NDA approval? The longer the wait the steeper the climb.